Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

Clinical trial NCT05754710 · RECRUITING

Trial details

NCT number: NCT05754710
Sponsor: Pfizer
Status: RECRUITING
Study type: OBSERVATIONAL

Psoriatic Arthritis, Juvenile Polyarticular Juvenile Idiopathic Arthritis

Start date: 2024-04-12
Primary completion: 2026-09-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.